Ioanna Gouni-Berthold Selected Research

Cytokine Receptor gp130

1/2019

The IL-6-neutralizing sIL-6R-sgp130 buffer system is disturbed in patients with type 2 diabetes.

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.

Realize the full power of the drug-disease research graph!

Ioanna Gouni-Berthold Research Topics

Disease

28	Cardiovascular Diseases (Cardiovascular Disease) 06/2022 - 07/2009
13	Atherosclerosis 05/2022 - 01/2002
12	Hypercholesterolemia 01/2022 - 02/2002
12	Hypertension (High Blood Pressure) 01/2020 - 09/2002
11	Type 2 Diabetes Mellitus (MODY) 01/2019 - 06/2004
11	Hyperlipoproteinemia Type II (Familial Hypercholesterolemia) 10/2018 - 01/2012
8	Inflammation (Inflammations) 01/2021 - 06/2004
6	Hypertriglyceridemia 06/2022 - 01/2013
5	Myocardial Infarction 01/2021 - 01/2011
5	Heart Failure 12/2020 - 08/2017
5	Dyslipidemias (Dyslipidemia) 01/2019 - 06/2004
4	Neoplasms (Cancer) 01/2021 - 09/2006
4	Pancreatitis 01/2021 - 11/2017
4	Injection Site Reaction 01/2021 - 01/2012
4	Coronary Disease (Coronary Heart Disease) 01/2019 - 05/2006
3	Stroke (Strokes) 01/2021 - 01/2011
3	Homozygous Familial Hypercholesterolemia 12/2016 - 05/2015
3	Metabolic Syndrome (Dysmetabolic Syndrome X) 01/2014 - 09/2002
2	Vitamin D Deficiency 01/2021 - 07/2009
2	Inborn Genetic Diseases (Disease, Hereditary) 02/2020 - 01/2014
2	Costello Syndrome 02/2020 - 01/2018
2	Aortic Valve Stenosis (Aortic Stenosis) 01/2020 - 01/2020
2	Obesity 01/2019 - 01/2013
2	Hyperlipoproteinemias 01/2013 - 11/2011
2	Hyperglycemia 01/2013 - 03/2006
2	Insulin Resistance 04/2008 - 01/2002
2	Bone Resorption 06/2004 - 04/2004
1	Peripheral Nervous System Diseases (PNS Diseases) 01/2022
1	Serum Sickness 01/2021
1	Vascular Diseases (Vascular Disease) 01/2021
1	Hyperlipoproteinemia Type I (Lipoprotein Lipase Deficiency, Familial) 02/2020
1	Human Influenza (Influenza) 01/2020
1	Vascular Calcification 01/2019

Drug/Important Bio-Agent (IBA)

20	oxidized low density lipoproteinIBA 05/2022 - 10/2002
19	Hydroxymethylglutaryl-CoA Reductase Inhibitors (HMG-CoA Reductase Inhibitors)IBA 06/2022 - 06/2004
15	LDL CholesterolIBA 05/2022 - 10/2004
13	LipidsIBA 01/2019 - 06/2004
10	evolocumabIBA 01/2021 - 12/2014
10	Lipoproteins (Lipoprotein)IBA 01/2018 - 09/2002
7	Vitamin D FDA LinkGeneric 01/2021 - 07/2009
7	CholesterolIBA 11/2017 - 02/2002
6	AntibodiesIBA 06/2022 - 12/2014
6	Triglycerides (Triacylglycerol)IBA 01/2021 - 06/2010
5	Lipoprotein(a)IBA 01/2020 - 01/2011
5	Glucose (Dextrose)FDA LinkGeneric 01/2014 - 09/2002
4	Antisense OligonucleotidesIBA 06/2022 - 01/2012
4	ISIS 304801IBA 01/2021 - 11/2017
4	alirocumabIBA 01/2018 - 12/2014
3	Apolipoprotein C-IIIIBA 06/2022 - 11/2017
3	Omega-3 Fatty Acids (Omega 3 Fatty Acids)IBA 01/2018 - 01/2013
3	Monoclonal AntibodiesIBA 01/2018 - 12/2014
3	Hypoglycemic Agents (Hypoglycemics)IBA 01/2017 - 01/2014
3	Atorvastatin (Lipitor)FDA Link 04/2016 - 06/2004
3	Ezetimibe (Zetia)FDA Link 02/2013 - 04/2008
3	LDL Lipoproteins (beta Lipoproteins)IBA 10/2004 - 01/2002
2	Cholecalciferol (Vitamin D3)FDA Link 03/2019 - 01/2019
2	25-hydroxyvitamin DIBA 01/2019 - 01/2018
2	Biomarkers (Surrogate Marker)IBA 01/2019 - 09/2002
2	Fibric Acids (Fibrates)IBA 01/2018 - 11/2017
2	HDL CholesterolIBA 01/2018 - 01/2014
2	Angiotensin Receptor AntagonistsIBA 01/2017 - 09/2015
2	Angiotensin-Converting Enzyme Inhibitors (ACE Inhibitors)IBA 01/2017 - 09/2015
2	Peptidyl-Dipeptidase A (Angiotensin Converting Enzyme)IBA 01/2017 - 09/2015
2	BMS201038IBA 01/2016 - 05/2015
2	mipomersenIBA 05/2015 - 01/2012
2	SeleniumIBA 05/2013 - 07/2012
2	Insulin (Novolin)FDA Link 01/2013 - 03/2006
2	AdipokinesIBA 01/2013 - 04/2008
2	Simvastatin (Zocor)FDA LinkGeneric 12/2011 - 06/2010
2	Phospholipids (Phosphatides)FDA LinkGeneric 11/2011 - 10/2002
2	GhrelinIBA 02/2010 - 01/2009
2	LeptinIBA 04/2008 - 09/2002
2	Hormones (Hormone)IBA 09/2006 - 03/2006
2	Blood Glucose (Blood Sugar)IBA 03/2006 - 09/2002
2	PPAR gammaIBA 02/2005 - 01/2002
2	Intercellular Signaling Peptides and Proteins (Growth Factors)IBA 10/2004 - 10/2002
2	collagen type I trimeric cross-linked peptideIBA 06/2004 - 04/2004
2	OsteocalcinIBA 06/2004 - 04/2004
1	(R)-2-(3-((benzoxazol-2-yl-d4 (3- (4- methoxyphenoxy- d7)propyl)amino)methyl)phenoxy) butanoic acidIBA 06/2022
1	Eicosapentaenoic AcidIBA 06/2022
1	eicosapentaenoic acid ethyl esterIBA 06/2022
1	AcidsIBA 06/2022
1	Coenzyme A (CoA)IBA 01/2022
1	Oxidoreductases (Dehydrogenase)IBA 01/2022
1	Investigational DrugsIBA 02/2020
1	AKCEA-APO(a)-LRxIBA 01/2020
1	Proprotein Convertase 9IBA 01/2020
1	Sex Hormone-Binding GlobulinIBA 03/2019
1	Testosterone (Sustanon)FDA Link 03/2019
1	Cytokine Receptor gp130IBA 01/2019
1	BuffersIBA 01/2019
1	alpha-2-HS-GlycoproteinIBA 01/2019
1	Interleukin-6 (Interleukin 6)IBA 01/2019
1	Proprotein Convertases (Pro-Opiomelanocortin Converting Enzyme)IBA 01/2018
1	ReninIBA 01/2018

Therapy/Procedure

14	Therapeutics 01/2021 - 12/2011
4	Drug Therapy (Chemotherapy) 01/2019 - 01/2013
2	Blood Component Removal (Apheresis) 01/2013 - 01/2013
2	Secondary Prevention 01/2011 - 05/2009
1	Injections 01/2021